Browse Guides  internal medicine  cardiology

Atrial fibrillation

Prevalence
Causes
Clinical features
Investigations
Therapy
Prevention
Prognosis
Therapy

DC cardioversion

Consider using transoesophageal echocardiography to determine when to perform the cardioversion a

  • No thrombus detected - DC cardioversion, and warfarin for 4 weeks. 
  • Thrombus detected - warfarin for 3 weeks, then repeated echocardiogram. 
    • If no thrombus then, DC cardioversion and warfarin for 4 weeks. 
    • If thrombus, no DC cardioversion and warfarin for 4 weeks.

Why?

  • Using transoesophageal echocardiography to determine when cardioversion should occur leads to fewer bleeds on warfarin but has no clear effect on embolic events or the duration of any sinus rhythm achieved. d
  • Using it to predict which patients require anticoagulation b has no clear effect on subsequent embolic events. d

Ibutilide is effective at cardioversion, but cause ventricular tachycardia

Patient Treatment Comparison Outcome CER RRR
(95% CI)
NNT
(95% CI)
AF for > 2 days or atrial flutter with a history of AF a DC cardioversion guided by transoesophageal echocardiography standard DC cardioversion haemorrhage
at 8 weeks
5.5% 47%
(7% to 70%)
39
(21 to 320)

 


Expiry date: February 2003
Levels of Evidence used in grading these guides

Authors   CM   Ball , N   Shenker
Reviewer   R G   Hart
CAT Writers   CM   Ball , N   Shenker , CJ   Wotton